Anaplastic lymphoma kinase - PDFSEARCH.IO - Document Search Engine

Anaplastic lymphoma kinase
Results: 91

#	Item
41	Public Summary Document Application No. 1250 – Testing of the anaplastic lymphoma kinase (ALK) gene in patients with non–small cell lung cancer to determine eligibility for treatment with crizotinib Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:15 Anatomical pathology Organofluorides Organochlorides Pfizer Crizotinib Anaplastic lymphoma kinase Non-small-cell lung carcinoma Protein kinase inhibitor Squamous-cell carcinoma Medicine Oncology Lung cancer
42	1250 Consultation Decision Analytic Protocol (DAP) to guide the assessment of diagnostic testing for Anaplastic Lymphoma Kinase (ALK) gene rearrangement in patients with advanced non-small cell lung cancer to determine e Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2015-03-20 01:49:45 Lung cancer Organofluorides Organochlorides Pfizer Quinazolines Crizotinib Non-small-cell lung carcinoma Anaplastic lymphoma kinase Protein kinase inhibitor Medicine Chemistry Oncology
43	PDF Document Add to Reading List Source URL: www.reptilepark.com.au Language: English - Date: 2014-03-21 23:17:00 Canines Dingo Anaplastic lymphoma kinase Fauna of Australia Mammals of Australia Australian Aboriginal culture
44	Instructions for Use Archer™ FusionPlex™ ALK, RET, ROS1 Panel v2 AK0028-8 Description Add to Reading List Source URL: archerdx.com Language: English - Date: 2015-02-19 18:39:00 ALK inhibitor Anaplastic lymphoma kinase Protein kinase inhibitor Crizotinib Tyrosine kinase ALK Organic chemistry ROS1 Illumina Biology Chemistry Organofluorides
45	Microsoft Word[removed]ALK-Final DAP.docx Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2015-03-20 01:49:46 Lung cancer Organofluorides Organochlorides Pfizer Quinazolines Crizotinib Non-small-cell lung carcinoma Anaplastic lymphoma kinase ALK inhibitor Medicine Chemistry Oncology
46	Microsoft Word[removed]Consultation DAP - ratified.doc Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:15 Lung cancer Organofluorides Organochlorides Pfizer Quinazolines Non-small-cell lung carcinoma Crizotinib Gefitinib Anaplastic lymphoma kinase Medicine Chemistry Oncology
47	Microsoft Word[removed]Consultation DAP - ratified.doc Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2015-03-20 01:49:45 Lung cancer Organofluorides Organochlorides Pfizer Quinazolines Non-small-cell lung carcinoma Crizotinib Gefitinib Anaplastic lymphoma kinase Medicine Chemistry Oncology
48	Microsoft Word[removed]ALK-Final DAP.docx Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:15 Lung cancer Organofluorides Organochlorides Pfizer Quinazolines Crizotinib Non-small-cell lung carcinoma Anaplastic lymphoma kinase ALK inhibitor Medicine Chemistry Oncology
49	Microsoft Word[removed]PSD-ALK testing for crizotinib-accessible (D14[removed]docx Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:15 Lung cancer Anatomical pathology Laboratory techniques Organofluorides Organochlorides Anaplastic lymphoma kinase Crizotinib Non-small-cell lung carcinoma Epidermal growth factor receptor Medicine Biology Oncology
50	Microsoft Word[removed]PSD - ALK testing for crizotinib-accessible.DOCX Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-12-03 00:24:13 Lung cancer Organofluorides Organochlorides Anatomical pathology Crizotinib Pyrazoles Non-small-cell lung carcinoma Anaplastic lymphoma kinase ALK inhibitor Medicine Oncology Chemistry